The performance has soared! 5 companies released important announcements such as a sharp rise in performance in the evening! (February 23).
1. Allist: 2023 Annual Results Express Announcement.
The company announced that during the reporting period, the company achieved a total operating income of 201,248560,000 yuan, a year-on-year increase of 15442%；Net profit attributable to owners of the parent company was 64,486050,000 yuan, a year-on-year increase of 39407%；Net profit attributable to owners of the parent company before non-recurring gains and losses was 59,990840,000 yuan, a year-on-year increase of 65579%。
2. Jinko Power: Announcement on the progress of repurchasing the company's shares to 1% through centralized bidding transactions.
The company announced that as of February 23, 2024, the company has repurchased a total of 41,495,687 shares of the company through centralized bidding transactions, and the proportion of repurchased shares to the company's total share capital is 116%, an increase of 027% with a low price of 314 yuan shares, the most traded ** is 369 shares, the total amount paid is RMB 13,999RMB 710,000 (excluding transaction costs).
3. Baike Biotechnology: 2023 Annual Performance Express Announcement.
The company announced that during the reporting period, the company's total operating income was 182,468880,000 yuan, compared to 107,144 in the same period last year600,000 yuan, a year-on-year increase of 7030%；Net profit attributable to owners of the parent company 50,100920,000 yuan, compared with 18,153 in the same period last year670,000 yuan, a year-on-year increase of 17598%；Net profit attributable to owners of the parent company before non-recurring gains and losses was 49,335$830,000, compared to $16,675 in the same period last year400,000 yuan, a year-on-year increase of 19586%。
4. Zhejiang Nature: Announcement on the implementation results of share repurchase.
The company announced that as of the date of this announcement, the company has completed the repurchase, and the actual repurchase of the company's shares is 1,284,560 shares, and the proportion of the purchased shares in the company's total share capital is 091%, and the most ** transaction is 2675 yuan shares, the lowest price is 1500 shares, the total amount paid is 30,016,13420 RMB (excluding transaction fees).
5. Huaheng Biotech: 2023 Annual Results Express Announcement.
The company announced that the company's total operating income in 2023 will be 193,880060,000 yuan, a year-on-year increase of 3666%；Realized net profit attributable to owners of the parent company was 45,074500,000 yuan, a year-on-year increase of 4084%。As of the end of the reporting period, the company's total assets were 397,416570,000 yuan, a year-on-year increase of 9605%；The owner's equity attributable to the parent company was 182,864470,000 yuan, a year-on-year increase of 2352%。